CT/NG Testing Market in terms of revenue was estimated to be worth $1.7 billion in 2023 and is poised to reach $2.7 billion by 2028, growing at a CAGR of 8.6% from 2023 to 2028 according to a new report by MarketsandMarkets™. Factors such as the increasing prevalence of CT/NG infections, increasing investments and funds in CT/NG and growing awareness for diseases diagnosis are driving the growth of this market. However, operational barriers and the high cost of CT/NG testing instruments is likely to hamper the growth of CT/NG testing market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104333528

Browse in-depth TOC on "CT/NG Testing Market"
95 - Tables
40 - Figures
200 - Pages

CT/NG Testing Market Scope:

Report Coverage

Details

Market Revenue in 2023

$1.7 billion

Estimated Value by 2028

$2.7 billion

Growth Rate

Poised to grow at a CAGR of 8.6%

Market Size Available for

2021–2028

Forecast Period

2023–2028

Forecast Units

Value (USD Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Product, testing type, technology, end user, and region

Geographies Covered

North America, Europe, Asia Pacific, Latin America, and Middle East Africa

Report Highlights

Updated financial information / product portfolio of players

Key Market Opportunities

Growing opportunities in emerging countries

Key Market Drivers

Increasing investments and funding to drive market growth

Assays Kits segment is expected to account for the largest share in 2022.

 Based on product, the CT/NG testing market is segmented into assays kits and instruments/analyzers. The large share of this segment is due to the recurrent and constant purchase requirement for the diagnosis of various infections and high-burden diseases including sexual health diseases such as CT/NG.

The INAAT segment held the largest market share in the CT/NG testing market.

Based on technology, the CT/NG testing market is broadly segmented into INAAT (isothermal nucleic acid amplification technology), PCR (polymerase chain reaction), immunodiagnostics and other technologies. The INAAT segment accounted for the largest share of the CT/NG testing market in 2022. The large share of the INAAT segment can be attributed to its high sensitivity, specificity and cost-effectiveness in CT/NG diagnosis.

North America dominates the global CT/NG testing market

Based on the region segmentation, the CT/NG testing market is divided into North AmericaEuropeAsia PacificLatin America, and Middle East Africa. North America holds the largest share and expects to dominate the CT/NG testing market. The large share of North America in this market can be attributed to the increasing prevalence of CT/NG, rising advancements in technology, and the growing healthcare system that is highly developed in the US and Canada.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=104333528

CT/NG Testing Market Dynamics:

Drivers:

  1. Increasing investments and funding to drive market growth

Restraints:

  1. High cost of instruments

Opportunities:

  1. Growing opportunities in emerging countries

Challenges:

  1. Operational barriers and shortage of skills across major markets

Key Market Players:

The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Hologic, Inc. (US), Thermo Fisher Scientific Inc. (US), Abbott Laboratories (US), QIAGEN (Netherlands), PerkinElmer Inc. (US), Bio-Rad Laboratories, Inc. (US), Siemens Healthineers AG (Germany), Danaher (US), Becton, Dickinson and Company (US), Seegene, Inc. (South Korea), Meridian Bioscience Inc. (US), Binx Health, Inc. (US), Visby Medical, Inc. (US), Geneproof A.S. (Czech Republic), Bioneer Corporation (South Korea), Genetic Signatures (Australia), Microbiologics, Inc. (US), Vircell S.L. (Spain), Sansure Biotech Inc. (China), ELITechGroup (France), Molbio Diagnostics Pvt. Ltd. (India), Operon S.A. (Spain), Tianlong Technology Co., Ltd.  (China), and Goffin Molecular Technologies B.V. (Netherlands).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=104333528